Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Novo Nordisk Really the Most Sustainable Company in the World?
Triple Pundit
Saturday, February 4, 2012 - 4:47pm
tags:
Novo Nordisk
Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
Yahoo/BusinessWire
Saturday, February 4, 2012 - 4:40pm
tags:
Pfizer, lawsuits, recalls
Eli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics
Bloomberg
Saturday, February 4, 2012 - 4:38pm
tags:
Eli Lilly, Zyprexa, generics
Curing Diseases Makes For a Bad Business Model (Vertex and Hepatitis C)
Motley Fool
Saturday, February 4, 2012 - 4:37pm
tags:
Vertex Pharmaceuticals, hepatitis C, Incivek
AstraZeneca - Solid Earnings Overwhelmed By An Uncertain Future
Seeking Alpha
Saturday, February 4, 2012 - 4:34pm
tags:
AstraZeneca
Merck Looks Like A Name To Own In Drugs
Seeking Alpha
Saturday, February 4, 2012 - 4:34pm
tags:
Merck
BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
Seeking Alpha
Saturday, February 4, 2012 - 3:36pm
tags:
BioLineRx
Brower Piven Files Class Action Suit Against GenVec, Inc
Yahoo/MarketWire
Saturday, February 4, 2012 - 3:34pm
tags:
GenVec, lawsuits
The 9 Biotechs With The Highest Growth Expectations
Seeking Alpha
Saturday, February 4, 2012 - 3:29pm
tags:
Theratechnologies, SeraCare Life Sciences, Gentium, Curis, BioDelivery Sciences, Amarin, Affymetrix, Affymax, Vertex Pharmaceuticals
What's Going on With These Biotech Stocks?
Motley Fool
Saturday, February 4, 2012 - 3:26pm
tags:
Cell Therapeutics, BioSante, Teva Pharmaceuticals, Aduro BioTech, Ariad Pharmaceuticals, Merck
Questcor Beats Estimates With Prelim Q4 Results
Investors.com
Saturday, February 4, 2012 - 3:24pm
tags:
Questcor Pharmaceuticals
Vical Inc.: A $3 Biotech Lottery Ticket I Am Buying Now
Seeking Alpha
Saturday, February 4, 2012 - 3:23pm
tags:
Vical, Allovectin, melanoma
What's behind call action in ViroPharma
Yahoo/Option Monster
Saturday, February 4, 2012 - 3:21pm
tags:
ViroPharma
Abbott, Hospira Win Appellate Affirmation in Spinoff Retirement Lawsuit
Bloomberg
Friday, February 3, 2012 - 12:36pm
tags:
Abbott Laboratories, Hospira
FDA talks, but doctors don't necessarily listen
Fierce Pharma
Friday, February 3, 2012 - 11:57am
tags:
FDA, physicians, warnings, Eli Lilly, Zyprexa, AstraZeneca, Seroquel
Idenix Falls Casualty to Gilead Hep C Hoopla
TheStreet.com
Friday, February 3, 2012 - 11:56am
tags:
Gilead, hepatitis C, Idenix
Questcor posts strong Q4 revenue, shares up
Reuters
Friday, February 3, 2012 - 11:55am
tags:
earnings, Questcor
Pharma Grows In Importance To India's Nifty Fifty
Seeking Alpha
Friday, February 3, 2012 - 11:52am
tags:
India
Amgen risk/reward attractive into Xgeva panel, says Deutsche Bank
Yahoo/Fly on the Wall
Friday, February 3, 2012 - 10:00am
tags:
Xgeva, Amgen, prostate cancer, advisory panels
AstraZeneca Declines Most in 5 Months on Forecast: London Mover
Bloomberg
Friday, February 3, 2012 - 9:58am
tags:
guidance, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.